ACE and hepatocellular carcinoma: Presently, several biomarkers have been used clinically or are under investigation for the early diagnosis of HCC, including alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP) and Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) and Golgi protein-73 (GP73).